Business Description
Advanced Proteome Therapeutics Corp
NAICS : 325410
SIC : 3741
ISIN : CA0076281009
Compare
Compare
Traded in other countries / regions
APC.H.Canada0E81.Germany IPO Date
1989-06-19Description
Advanced Proteome Therapeutics Corp is a biotechnology company. It develops and commercializes a platform to use protein modification technologies to create proprietary human protein pharmaceuticals with therapeutic properties. The company develops anti-cancer drugs for cancerous tumors that will destroy a cancer patient's tumor cells selectively, sparing healthy cells. All the operations of the organization are principally carried out in the United States.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Advanced Proteome Therapeutics Corp Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | |||
| EPS (TTM) (C$) | -0.094 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.25 | ||
| 3-Year Sortino Ratio | -0.33 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR (C$) | - | ||
| 20-Day SMA (C$) | 0.005 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (C$) | 0.005 - 0.005 | ||
| Shares Outstanding (Mil) | 41.13 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Advanced Proteome Therapeutics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Advanced Proteome Therapeutics Corp Stock Events
| Event | Date | Price (C$) | ||
|---|---|---|---|---|
| 0.1:1 Stock Split | 2019-05-08 | 0.20 (+0.00%) |
Show
Entries
Advanced Proteome Therapeutics Corp Frequently Asked Questions
What is Advanced Proteome Therapeutics Corp(TSXV:APC.H)'s stock price today?
The current price of TSXV:APC.H is C$0.01. The 52 week high of TSXV:APC.H is C$0.01 and 52 week low is C$0.01.
When is next earnings date of Advanced Proteome Therapeutics Corp(TSXV:APC.H)?
The next earnings date of Advanced Proteome Therapeutics Corp(TSXV:APC.H) is .
Does Advanced Proteome Therapeutics Corp(TSXV:APC.H) pay dividends? If so, how much?
Advanced Proteome Therapeutics Corp(TSXV:APC.H) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Advanced Proteome Therapeutics Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers